Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 11.90% is 50% below its 5-year average of 23.75%, near the low end of its 5-year range (11.90%–31.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.72% below its 12-month average of 21.53%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
11.90%
EBITDA MARGIN AVG TTM
21.53%
EBITDA MARGIN AVG 3Y
24.63%
EBITDA MARGIN AVG 5Y
23.75%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-44.72%
CURRENT VS 3Y AVG
-51.67%
CURRENT VS 5Y AVG
-49.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$32.39B
EBITDA Margin
16.19%
TTM Avg
16.24%
3Y Avg
16.31%
5Y Avg
17.37%
Market Cap
$31.58B
EBITDA Margin
15.00%
TTM Avg
4.83%
3Y Avg
-18.55%
5Y Avg
-52.26%
Market Cap
$30.94B
EBITDA Margin
34.73%
TTM Avg
34.58%
3Y Avg
34.05%
5Y Avg
33.84%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alcon Inc. (ALC) | $34.85B | 11.90% | 21.53% | 24.63% | 23.75% |
| ResMed Inc. (RMD)vs › | $34.61B | 36.98% | 37.16% | 34.64% | 34.36% |
| DexCom, Inc. (DXCM)vs › | $34.12B | 24.96% | 22.62% | 21.42% | 19.95% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.39B | 16.19% | 16.24% | 16.31% | 17.37% |
| Zoetis Inc. (ZTS)vs › | $32.22B | 43.14% | 42.58% | 42.20% | 41.87% |
| Biogen Inc. (BIIB)vs › | $32.14B | 28.67% | 30.68% | 30.30% | 31.44% |
| Centene Corp. (CNC)vs › | $31.85B | -3.26% | -0.27% | 1.02% | 1.75% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.58B | 15.00% | 4.83% | -18.55% | -52.26% |
| Waters Corporation (WAT)vs › | $30.94B | 34.73% | 34.58% | 34.05% | 33.84% |
| Medline Inc. (MDLN)vs › | $29.83B | 10.26% | 11.41% | 10.38% | 10.38% |
Gross Margin
56.4%
EBITDA Margin
11.9%
Operating Margin
10.3%
Net Margin
6.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 11.90% |
| 2026-03-31 | 25.98% |
| 2025-12-31 | 20.97% |
| 2025-09-30 | 25.35% |
| 2025-06-30 | 23.46% |
| 2025-03-31 | 31.46% |
| 2024-12-31 | 26.94% |
| 2024-09-30 | 25.26% |
| 2024-06-30 | 25.20% |
| 2024-03-31 | 26.67% |
| 2023-12-31 | 22.82% |
| 2023-09-30 | 24.82% |
| 2023-06-30 | 23.41% |
| 2023-03-31 | 24.29% |
| 2022-12-31 | 15.66% |
| 2022-09-30 | 21.43% |
| 2022-06-30 | 23.64% |
| 2022-03-31 | 23.26% |
| 2021-12-31 | 20.60% |
| 2021-09-30 | 21.14% |
| 2021-06-30 | 22.34% |
| 2021-03-31 | 21.89% |
| 2020-12-31 | 28.76% |
| 2020-09-30 | 16.00% |
| 2020-06-30 | -4.86% |
| 2020-03-31 | 18.85% |
| 2019-12-31 | 14.58% |
| 2019-09-30 | 16.97% |
| 2019-06-30 | 14.82% |
| 2019-03-31 | 16.23% |
| 2018-12-31 | 13.24% |
| 2018-09-30 | 23.21% |
| 2018-06-30 | 19.53% |
| 2018-03-31 | 21.69% |
| 2017-12-31 | 10.61% |
